共 271 条
- [1] Molinaro E(2017)Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies Nat Rev Endocrinol. 13 644-660
- [2] Romei C(2019)Clinical trials in management of anaplastic thyroid carcinoma; progressions and set backs: a systematic review Int J Endocrinol Metabol 17 e67759-681
- [3] Biagini A(2017)Patterns of treatment failure in anaplastic thyroid carcinoma Thyroid. 27 672-59663
- [4] Sabini E(2013)Treatment and prognosis of anaplastic thyroid carcinoma: experience from a single institution in China PLoS ONE 8 e80011-e103
- [5] Agate L(2016)Interleukin-11 promotes epithelial–mesenchymal transition in anaplastic thyroid carcinoma cells through PI3K/Akt/GSK3beta signaling pathway activation Oncotarget. 7 59652-1474
- [6] Mazzeo S(2018)Lnk/Sh2b3 deficiency restores hematopoietic stem cell function and genome integrity in Fancd2 deficient Nat Commun 9 3915-20604
- [7] Materazzi G(2016)LNK/SH2B3 loss of function promotes atherosclerosis and thrombosis Circ Res 119 e91-1571
- [8] Sellari-Franceschini S(2014)LNK (SH2B3): paradoxical effects in ovarian cancer Oncogene 34 1463-1281
- [9] Ribechini A(2013)Lnk adaptor suppresses radiation resistance and radiation-induced B-cell malignancies by inhibiting IL-11 signaling Proc Natl Acad Sci 110 20599-1024
- [10] Torregrossa L(2019)The BRISC de-ubiquitinating enzyme complex limits hematopoietic stem cell expansion by regulating JAK2 K63-ubiquitination Blood 133 1560-1894